Back to Search
LINDSAY MARK, PHARMD
PHARMD
Pharmacist
NPI: 1306222617Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Cerebral venous thrombosis presenting with subarachnoid hemorrhage. Case report and review.
PMID 19041540·Am J Emerg Med·2009
5-case
Characterization of the complement inhibitory function of rhesus rhadinovirus complement control protein (RCP).
PMID 18990693·J Biol Chem·2009
7-preclinical
Effects of ezetimibe on lipids and lipoproteins in patients with hypercholesterolemia and different apolipoprotein E genotypes.
PMID 17559752·Curr Med Res Opin·2007
3-trial
Molecular characterization of the rhesus rhadinovirus (RRV) ORF4 gene and the RRV complement control protein it encodes.
PMID 17287274·J Virol·2007
7-preclinical
Kaposi's sarcoma-associated herpes virus complement control protein: KCP--complement inhibition and more.
PMID 16905191·Mol Immunol·2007
6-review
The Kaposi's sarcoma-associated herpesvirus complement control protein (KCP) binds to heparin and cell surfaces via positively charged amino acids in CCP1-2.
PMID 16442624·Mol Immunol·2006
7-preclinical
A validated HPLC method for the quantitative analysis of trans-resveratrol and trans-piceid in Hungarian wines.
PMID 16212788·J Chromatogr Sci·2005
4-observational
Inhibition of nitric oxide synthase reduces renal ischemia/reperfusion injury.
PMID 16140334·J Surg Res·2005
7-preclinical
The Kaposi's sarcoma-associated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system.
PMID 15304516·J Biol Chem·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 201 STATE ST
ERIE, PA 16550 - Phone
- (814) 877-5166
Quick Facts
- NPI
- 1306222617
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile